COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,631 Articles (22,913 medRxiv, 8,718 bioRxiv)

Most recent first Previous |  Page 485: Articles 4841-4850  | Next

Human Surfactant Protein A Alleviates SARS-CoV-2 Infectivity in Human Lung Epithelial Cells
Jacob, I. B., Gemmiti, A., Xiong, W., Reynolds, E., Nicholas, B., Thangamani, S., Jia, H., Wang, G.
10.1101/2023.04.03.535215 — Posted: 2023-04-03
A broadly protective CHO cell expressed recombinant spike protein subunit based vaccine (IMT-CVAX) against SARS-CoV-2
Jitender, , Kumar, B. V., Singh, S., Verma, G., Kumar, R., Mishra, P. M., Kumar, S., Nagaraj, S. K., Nag, J., Joy, C. M., Nikam, B., Singh, D., Pooja, , Kalidas, N., Singh, S., Mumtaz, , Bhardwaj, A. K., Mankotia, D. S., Ringe, R. P., Gupta, N., Tripathi, S., Mishra, R. P.
10.1101/2023.04.03.534161 — Posted: 2023-04-03
nanoCLAMP potently neutralizes SARS-CoV-2 and protects K18-hACE2 mice from infection
Pagneux, Q., Garnier, N., Fabregue, M., Sharkaoui, S., Mazzoli, S., Engelmann, I., Boukherroub, R., Strecker, M., Cruz, E., Ducos, P., Zarubica, A., Suderman, R., Szunerits, S.
10.1101/2023.04.03.535401 — Posted: 2023-04-03
Community structure and temporal dynamics of SARS-CoV-2 epistatic network allows for early detection of emerging variants with altered phenotypes
Mohebbi, F., Zelikovsky, A., Mangul, S., Chowell, G., Skums, P.
10.1101/2023.04.02.535277 — Posted: 2023-04-03
Exploratory Study to Characterise the Individual Types of Health Literacy and Beliefs and Their Associations with Infection Prevention Behaviours amid the COVID-19 Pandemic in Japan: A Longitudinal Study
YAGIHASHI, M., Murakami, M., Kato, M., Yamaura, M., Miura, A., Hirai, K.
10.1101/2023.04.02.23287895 — Posted: 2023-04-03
Knowledge of COVID-19 Symptoms, Transmission, and Prevention: Evidence from Health and Demographic Surveillance in Southern Mozambique
Nhacolo, A., Madewell, Z. J., Muir, J. A., Sacoor, C., Xerinda, E. G., Matsena, T., Bassat, Q., Whitney, C. G., Mandomando, I., Cunningham, S. A.
10.1101/2023.03.31.23288026 — Posted: 2023-04-03
Pharmaceutical and Non-Pharmaceutical Interventions for Controlling the COVID-19 Pandemic
Molla, J., Farhang-Sardroodi, S., Moyles, I. R., Heffernan, J. M.
10.1101/2023.03.31.23288023 — Posted: 2023-04-03
A Graph Embedding Approach for Deciphering the Longitudinal Associations of Global Mobility and COVID-19 Cases
Awasthi, R., Modi, M., Dudeja, H., Bajaj, T., Rastogi, S., Sethi, T.
10.1101/2023.03.30.23287969 — Posted: 2023-04-03
Trends in weight gain recorded in English primary care before and during the Coronavirus-19 pandemic: an observational cohort study using the OpenSAFELY platform
Samuel, M., Park, R. Y., Eastwood, S. V., Eto, F., Morton, C. E., Stow, D., Bacon, S., Mehrkar, A., Morley, J., Dillingham, I., Inglesby, P., Hulme, W. J., Khunti, K., Mathur, R., Valabhji, J., MacKenna, B., Finer, S., The OpenSAFELY Collaborative
10.1101/2023.04.01.23287538 — Posted: 2023-04-03
A nationwide multistate analysis estimating the rates and risks of transferring critically ill COVID-19 patients during the Delta and Omicron waves in Germany
Lottes, M., Grodd, M., Grabenhenrich, L., Wolkewitz, M.
10.1101/2023.03.31.23287964 — Posted: 2023-04-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).